183 related articles for article (PubMed ID: 38191874)
1. BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.
Das D; Leung JY; Balamurugan S; Tergaonkar V; Loh AHP; Chiang CM; Taneja R
EMBO Rep; 2024 Feb; 25(2):832-852. PubMed ID: 38191874
[TBL] [Abstract][Full Text] [Related]
2. BRD4 isoforms have distinct roles in tumor progression and metastasis in embryonal rhabdomyosarcoma.
Das D; Leung JY; Tergaonkar V; Loh AHP; Chiang CM; Taneja R
bioRxiv; 2023 Jul; ():. PubMed ID: 37546805
[TBL] [Abstract][Full Text] [Related]
3. Opposing Functions of BRD4 Isoforms in Breast Cancer.
Wu SY; Lee CF; Lai HT; Yu CT; Lee JE; Zuo H; Tsai SY; Tsai MJ; Ge K; Wan Y; Chiang CM
Mol Cell; 2020 Jun; 78(6):1114-1132.e10. PubMed ID: 32446320
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
Srivastava RK; Guroji P; Jin L; Mukhtar MS; Athar M
Mol Carcinog; 2022 Aug; 61(8):737-751. PubMed ID: 35472745
[TBL] [Abstract][Full Text] [Related]
5. Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.
Werner MT; Wang H; Hamagami N; Hsu SC; Yano JA; Stonestrom AJ; Behera V; Zong Y; Mackay JP; Blobel GA
J Biol Chem; 2020 Feb; 295(7):1898-1914. PubMed ID: 31792058
[TBL] [Abstract][Full Text] [Related]
6. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
7. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
[TBL] [Abstract][Full Text] [Related]
8. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.
Gryder BE; Yohe ME; Chou HC; Zhang X; Marques J; Wachtel M; Schaefer B; Sen N; Song Y; Gualtieri A; Pomella S; Rota R; Cleveland A; Wen X; Sindiri S; Wei JS; Barr FG; Das S; Andresson T; Guha R; Lal-Nag M; Ferrer M; Shern JF; Zhao K; Thomas CJ; Khan J
Cancer Discov; 2017 Aug; 7(8):884-899. PubMed ID: 28446439
[TBL] [Abstract][Full Text] [Related]
9. FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
Tzani A; Haemmig S; Cheng HS; Pérez-Cremades D; Heuschkel MA; Jamaiyar A; Singh SA; Aikawa M; Yu PB; Wang T; Sun Y; Feinberg MW; Plutzky J
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):143-155. PubMed ID: 37942611
[TBL] [Abstract][Full Text] [Related]
10. Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
Ren C; Zhang G; Han F; Fu S; Cao Y; Zhang F; Zhang Q; Meslamani J; Xu Y; Ji D; Cao L; Zhou Q; Cheung KL; Sharma R; Babault N; Yi Z; Zhang W; Walsh MJ; Zeng L; Zhou MM
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7949-7954. PubMed ID: 30012592
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target.
Zhang M; Huang H; Wei M; Sun M; Deng G; Hu S; Wang H; Gong Y
Curr Cancer Drug Targets; 2024; 24(2):167-177. PubMed ID: 37282642
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.
Kim SY; Zhang X; Schiattarella GG; Altamirano F; Ramos TAR; French KM; Jiang N; Szweda PA; Evers BM; May HI; Luo X; Li H; Szweda LI; Maracaja-Coutinho V; Lavandero S; Gillette TG; Hill JA
Circulation; 2020 Dec; 142(24):2356-2370. PubMed ID: 33113340
[TBL] [Abstract][Full Text] [Related]
13. IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors.
Wu SY; Lai HT; Sanjib Banerjee N; Ma Z; Santana JF; Wei S; Liu X; Zhang M; Zhan J; Chen H; Posner B; Chen Y; Price DH; Chow LT; Zhou J; Chiang CM
Mol Cell; 2024 Jan; 84(2):202-220.e15. PubMed ID: 38103559
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.
Wang R; Li Q; Helfer CM; Jiao J; You J
J Biol Chem; 2012 Mar; 287(14):10738-52. PubMed ID: 22334664
[TBL] [Abstract][Full Text] [Related]
15. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
[TBL] [Abstract][Full Text] [Related]
16. A deregulated m
Lu X; Peng L; Ding J; Li Y; Li Q; Rao M; Shu T; He X; Liu C; Ye J; Liu W; You H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304534120. PubMed ID: 37782793
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Bromodomain and Extraterminal Domain is Associated with Progression, Metastasis and Unfavorable Outcomes: Highlighting Prognostic and Therapeutic Value of the BET Protein Family in Gastric Cancer.
Fard SS; Kouchaki S; Salimian Z; Sotoudeh M; Mousavi SA; Alimoghaddam K; Ghaffari SH
Anticancer Agents Med Chem; 2023; 23(7):794-806. PubMed ID: 36284375
[TBL] [Abstract][Full Text] [Related]
19. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1.
Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
[TBL] [Abstract][Full Text] [Related]
20. [Advances of structure and mechanisms of bromodomain-containing protein 4 and its related research in tumors].
Huang Q; Ding Y; Tan Y; Mo W; Li T; Huang Y; Hao W
Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):132-148. PubMed ID: 36738206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]